Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 10;2(1):e167.
doi: 10.1017/ash.2022.302. eCollection 2022.

Outcomes among patients with Staphylococcus aureus bacteremia enrolled in a postdischarge outpatient parenteral antibiotic therapy program at an academic medical center

Affiliations

Outcomes among patients with Staphylococcus aureus bacteremia enrolled in a postdischarge outpatient parenteral antibiotic therapy program at an academic medical center

Deborah A Theodore et al. Antimicrob Steward Healthc Epidemiol. .

Abstract

We compared patients with Staphylococcus aureus bacteremia enrolled in outpatient parenteral antibiotic therapy monitoring program (OPAT-MP) upon hospital discharge with patients not enrolled. OPAT-MP patients were more likely to attend infectious diseases follow-up appointments. OPAT-related emergency room visits and/or readmissions were more common among non-OPAT-MP patients, but differences were not statistically significant.

PubMed Disclaimer

References

    1. Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009;64:1316–1324. - PubMed
    1. Keller SC, Williams D, Gavgani M, et al. Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy. Clin Infect Dis 2018;66:11–19. - PMC - PubMed
    1. Billmeyer K, Galdys A, Kline S, Hirsch E, Ross J, Evans M. Retrospective cohort analysis of the safety of outpatient parenteral antimicrobial therapy (OPAT) in an academic hospital. Antimicrob Steward Healthc Epidemiol 2022;2:S59–S59.
    1. Kaul C, Yang J, Haller M, et al. Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications. Antimicrob Steward Healthc Epidemiol 2022;2:S18–S18. - PMC - PubMed
    1. Ng N, Bailey P, Pryor R, et al. Experiences in outpatient parenteral antimicrobial therapy (OPAT): barriers and challenges from the front lines. Antimicrob Steward Healthc Epidemiol 2021;1:E42. - PMC - PubMed

LinkOut - more resources